CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 1,300 shares at $0.51 ($660)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Scientific Officer acquired 55,120 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Other acquisition 10% owner acquired 1,042,431 shares (other)
- 4 Other acquisition 10% owner acquired 700,066 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Other acquisition 10% owner acquired 261,969 shares (other)
- 4 Open-market buy Chief Scientific Officer bought 449 shares at $4.42 ($1,985)
- 4 Other acquisition 10% owner acquired 74,240 shares (other)
- 4 Other acquisition 10% owner acquired 337,452 shares (other)
- 4 Other acquisition 10% owner acquired 176,586 shares (other)
- 4 Other acquisition 10% owner acquired 38,851 shares (other)
- 4 Exercise or conversion President and CEO acquired 183,347 shares (option exercise)
- 4 Open-market buy Director bought 5,100 shares at $1.95 ($9,963)
- 4 Open-market buy Director bought 97,410 shares at an average $1.92 ($187,450)
- 4 Open-market buy Director bought 147,130 shares at an average $1.76 ($259,356)
- 4 Other acquisition 10% owner acquired 67,851 shares (other)
- 4 Other acquisition 10% owner acquired 308,412 shares (other)
Page 16 of 34 · 675 filings